Survival of castration‐resistant prostate cancer patients treated with dendritic–tumor cell hybridomas is negatively correlated with changes in peripheral blood CD56brightCD16− natural killer cells

• Helena Haque Chowdhury,
• Simon Hawlina,
• Mateja Gabrijel,
• Saša Trkov Bobnar,
• Marko Kreft,
• Gordan Lenart,
• Marko Cukjati,
• Andreja Nataša Kopitar,
• Nataša Kejžar,
• Alojz Ihan,
• Luka Ležaič,
• Marko Grmek,
• Andrej Kmetec,
• Matjaž Jeras,
• Robert Zorec

Affiliations

Helena Haque Chowdhury

Laboratory of Cell Engineering Celica Biomedical Ljubljana Slovenia

Simon Hawlina

Clinical Department of Urology University Medical Centre Ljubljana Ljubljana Slovenia

Mateja Gabrijel

Laboratory of Cell Engineering Celica Biomedical Ljubljana Slovenia

Saša Trkov Bobnar

Laboratory of Cell Engineering Celica Biomedical Ljubljana Slovenia

Marko Kreft

Laboratory of Cell Engineering Celica Biomedical Ljubljana Slovenia

Gordan Lenart

Clinical Department of Urology University Medical Centre Ljubljana Ljubljana Slovenia

Marko Cukjati

Blood Transfusion Centre of Slovenia Ljubljana Slovenia

Andreja Nataša Kopitar

Institute of Microbiology and Immunology, Faculty of Medicine University of Ljubljana Ljubljana Slovenia

Nataša Kejžar

Institute for Biostatistics and Medical Informatics, Faculty of Medicine University of Ljubljana Ljubljana Slovenia

Alojz Ihan

Institute of Microbiology and Immunology, Faculty of Medicine University of Ljubljana Ljubljana Slovenia

Luka Ležaič

Department of Nuclear Medicine University Medical Centre Ljubljana Ljubljana Slovenia

Marko Grmek

Department of Nuclear Medicine University Medical Centre Ljubljana Ljubljana Slovenia

Andrej Kmetec

Clinical Department of Urology University Medical Centre Ljubljana Ljubljana Slovenia

Matjaž Jeras

Laboratory of Cell Engineering Celica Biomedical Ljubljana Slovenia

Robert Zorec

Laboratory of Cell Engineering Celica Biomedical Ljubljana Slovenia